This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Huan Yang Articles by Tracey, K. J. Search for Related Content PubMed PubMed Citation Articles by Huan Yang, Articles by Tracey, K. J. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Social Bookmarking                         What's this?

HMGB1 as a cytokine and therapeutic target

Laboratory of Biomedical Science, North Shore-Long Island Jewish Research Institute, Manhasset, New York, USA, hyang{at}nshs.edu

Haichao Wang

Laboratory of Biomedical Science, North Shore-Long Island Jewish Research Institute, Manhasset, New York, USA

Christopher J. Czura

Laboratory of Biomedical Science, North Shore-Long Island Jewish Research Institute, Manhasset, New York, USA

Kevin J. Tracey

Laboratory of Biomedical Science, North Shore-Long Island Jewish Research Institute, Manhasset, New York, USA

HMGB1 is an abundant nuclear and cytoplasmic protein present in mammalian cells. It is traditionally known as a DNA binding protein involved in maintenance of nucleosome structure and regulation of gene transcription. Beyond these intracellular roles, we recently discovered that HMGB1 is released from activated macrophages and functions as a late mediator of lethal endotoxemia. Addition of HMGB1 to macrophage cultures activates cytokine release. When released into the extracellular milieu, HMGB1 causes systemic inflammatory responses including acute lung injury, epithelial barrier dysfunction, and death. Passive immunization with anti-HMGB1 antibodies confers significant protection against lethality induced by LPS administration and sepsis caused by cecal perforation in mice. Truncation of HMGB1 into individual structural domains revealed that the HMGB1 A box, a DNA-binding motif, specifically antagonizes the activity of HMGB1 and rescues mice from lethal sepsis caused by cecal perforation. Thus, strategies that target HMGB1 with specific antibodies or antagonists have potential for treating lethal systemic inflammatory diseases characterized by excessive HMGB1 release.

Journal of Endotoxin Research, Vol. 8, No. 6, 469-472 (2002)
DOI: 10.1177/09680519020080060301


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?